Cas 220895-45-4,5-methoxy-4-(3-morpholinopropoxy)-2-nitrobenzoic acid trifluoroacetate

220895-45-4

Post Buying Request

Basic information

Product Name: 5-methoxy-4-(3-morpholinopropoxy)-2-nitrobenzoic acid trifluoroacetate
Synonyms: 5-methoxy-4-(3-morpholinopropoxy)-2-nitrobenzoic acid trifluoroacetate
CAS NO:220895-45-4
Molecular Formula:
Molecular Weight: 454.357
EINECS: N/A
Product Categories: N/A
Mol File: 220895-45-4.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 5-methoxy-4-(3-morpholinopropoxy)-2-nitrobenzoic acid trifluoroacetate(CAS DataBase Reference)
NIST Chemistry Reference: 5-methoxy-4-(3-morpholinopropoxy)-2-nitrobenzoic acid trifluoroacetate(220895-45-4)
EPA Substance Registry System: 5-methoxy-4-(3-morpholinopropoxy)-2-nitrobenzoic acid trifluoroacetate(220895-45-4)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 220895-45-4(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

220895-45-4 Suppliers

Recommended suppliersmore

220895-45-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 220895-45-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,0,8,9 and 5 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 220895-45:
(8*2)+(7*2)+(6*0)+(5*8)+(4*9)+(3*5)+(2*4)+(1*5)=134
134 % 10 = 4
So 220895-45-4 is a valid CAS Registry Number.

220895-45-4Upstream product

196603-84-6 3-methoxy-4-(3-morpholinopropoxy)benzoic acid

220895-45-4Downstream Products

196603-86-8 5-methoxy-4-(3-morpholinopropoxy)-2-nitrobenzamide

220895-45-4Relevant articles and documents

Oxindolylquinazoline derivatives as angiogenesis inhibitors

-

, (2008/06/13)

The invention relates to compounds of formula (I) and salts thereof as further defined herein, wherein ring Z is a 6-membered heterocyclic ring containing 1 to 3 nitrogen atoms, and the use of such compounds and salts to inhibit the effects of VEGF and FGF, and in the treatment of a number of disease states including cancer and rheumatoid arthritis.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 220895-45-4